Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of duloxetine in SUI
NCT00191204Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of duloxetine in stress urinary incontinence (SUI), sponsored by Eli Lilly and Company. Primary endpoint: Long-term safety data. Started Sep 2001; status: completed.
02
Drugs
duloxetine
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT00191204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00191204.